COMPANY · NIPC 506134466

Instituto de Medicina Molecular

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €1,542,944 across 3 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameInstituto de Medicina Molecular
NIPC506134466

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2017 to 2022. The table below gives the same values.2017: €3,02420172021: €688,08020212022: €851,8402022€851,840
Contracted value by year
YearContractsContract value
20171€3,024
20211€688,080
20221€851,840
Contracted value by buyer
NameContractsContract value
Instituto da Segurança Social, I. P.2€1,539,920
Instituto Nacional de Investigação Agrária e Veterinária, I. P.1€3,024
Contracted value by place of performance
NameContractsContract value
Oeiras1€3,024
Largest contracts
SubjectYearContract value
Aquisição de serviços para realização de Testes PCR em ERPI e Lar Residencial 2022 - iMM2022€851,840
Realização de Testes PCR em ERPI e Lar Residencial - 81 Concelhos2021€688,080
Análises de genotipagem de prnp em ovinos EETs positivos2017€3,024

Who they competed with

The IMPIC files list no competitors for this company's contracts.

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

The documents we read show no links between these companies.

Investigations that mention it

No published investigation mentions this company by NIPC.